Today's Top 20 Gastroenterology and Endoscopy Stories
-
At-home options boost CRC screening rates, study finds
A study of Kaiser Permanente members in Southern California found that offering patients to self-order a colorectal cancer screening test online increases rates of test completion, according to a Jan. 21 news release. -
Top GI articles — GI group merges with hospital; One GI's growth plan and more
Here are the most-read GI articles during the week of Jan. 18-22: -
CMS declines to reimburse for 1st FDA-approved blood-based CRC screening test
The FDA declined to extend National Coverage Determination to Epigenomics AG for its Epi proColon, a blood-based colorectal cancer screening test, the company announced Jan. 21. -
GI tract hides COVID-19-related receptors in some patients, study says
Barrett's esophagus patients may be more vulnerable to COVID-19 infection in their upper gastrointestinal tract after eating or drinking food contaminated with the virus, according to a study published Jan. 20 in Gastroenterology. -
CMS colonoscopy quality measure may be inaccurate, study says
Patients who received an outpatient colonoscopy seldom go to the emergency rooms for unplanned complications, and of those who do it's often for reasons unrelated to the procedure, according to a study published in Clinical and Experimental Gastroenterology. -
Missouri gastroenterologist forms PPE plant
Gastroenterologist Farid Namin, MD, opened a personal protective equipment manufacturer after overcoming procurement obstacles early in the pandemic, the Kansas City Business Journal reported Jan. 19. -
Physicians Endoscopy part of joint venture; GI Alliance partners for research — 5 GI industry notes
Here are five updates from GI practices and companies from the past week: -
The story behind the Assured Healthcare Partners & Allied Digestive Health deal
Investing firm Assured Healthcare Partners and West Long Branch, N.J.-based Allied Digestive Health struck a deal Jan. 13. -
GI Alliance partners with research organization
GI Alliance partnered with ObvioHealth, a research organization, to create decentralized clinical trial designs, according to a Jan. 19 news release. -
Liquid biopsy test detected patients at risk for CRC relapse
A liquid biopsy test that detects circulating tumor DNA identified patients likely to redevelop colorectal cancer after having undergone surgery to remove tumors, Medpage Today reported Jan. 17. -
A home for independent GIs — Exploring One GI's plans to go from 58 providers to 140 in Q1
Memphis, Tenn.-based One GI ended 2020 with a pair of post-formation deals and has no plans of stopping as 2021 kicks off. -
Physician-owned GI group merges with Florida hospital
West Palm Beach, Fla.-based Gastro Group of the Palm Beaches joined Tampa (Fla.) General Hospital, the Town-Crier reported Jan. 14. -
Exact Sciences' $58B bet on diagnostic screening & 4 other updates from the company's busy week
Between presenting at the 39th Annual JP Morgan Healthcare Conference, acquiring an asset that boosted its precision oncology line, and presenting its preliminary fourth-quarter 2020 results, Exact Sciences had a busy week. -
Pennsylvania GI center grows to 17 physicians
Wyomissing, Pa.-based Berks Center for Digestive Health added three physicians through its partnership with Physicians Endoscopy, according to a Jan. 14 news release. -
Ohio hospital expanding GI services
Cincinnati-based Mercy Health is developing a medical complex with a 60-bed hospital and a medical office building in Mason, Ohio, local news affiliate Local 12 reported Jan. 13. -
Top GI articles — Pandemic's toll, Pinnacle Partners' 1st transaction and more
Here are the most-read GI articles during the week of Jan. 11-15: -
Former Trump physician, GI Dr. Harold Bornstein dead at 73
Harold Bornstein, MD, the former personal physician for President Donald Trump, died Jan. 8, at 73, The New York Times reported Jan. 14. -
CRC blood tests, partnerships and more — 4 GI industry notes
Here are four updates from GI companies and practices over the past week: -
Assured Healthcare Partners strikes deal with with Allied Digestive Health
Investing firm Assured Healthcare Partners partnered with West Long Branch, N.J.-based Allied Digestive Health, it announced Jan. 13. -
New blood test detects CRC advanced adenomas, study says
Freenome's novel multiomics blood test for colorectal cancer detected advanced adenomas with a 41 percent sensitivity at 90 percent specificity, according to results from its Ai-Emerge study.